stockportfolio.pro
Core Laboratories Inc. (CLB)
Energy · Oil & Gas Equipment & Services · NYSE
Core Laboratories Inc. revenue & earnings — last 5 fiscal years
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $470.25M | $489.74M | $509.79M | $523.85M | $526.52M |
| Gross profit | — | $96.08M | $109.83M | $103.33M | $108.93M |
| Net income | $19.73M | $19.45M | $40.94M | $31.40M | $31.80M |
| Net margin | 4.2% | 4.0% | 8.0% | 6.0% | 6.0% |
Source: Core Laboratories Inc. SEC filings (10-K).
What growth is priced into CLB stock?
At today's market cap of $617.00M, Core Laboratories Inc. is priced for free-cash-flow growth of about 10.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $25.82M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 5 years of Core Laboratories Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CLB in your portfolio →
Core Laboratories Inc. financial history by metric
About Core Laboratories Inc.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Core Laboratories Inc. — frequently asked questions
What is Core Laboratories Inc.'s revenue?
Core Laboratories Inc. (CLB) reported revenue of $526.52M for fiscal year 2025, up 0.5% from the prior year, according to its SEC filings.
Is Core Laboratories Inc. profitable?
Yes. CLB earned net income of $31.80M in fiscal 2025, a net margin of 6.0%.
What is CLB's P/E ratio?
Core Laboratories Inc. trades at a price-to-earnings ratio of about 21.9 based on the latest data in our nightly-refreshed cache.
How fast is Core Laboratories Inc. growing?
CLB's revenue grew at roughly 2.9% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Core Laboratories Inc. have?
As of fiscal year 2025, CLB carried roughly $113.00M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Core Laboratories Inc.'s gross margin?
CLB's gross margin was 20.7% in fiscal 2025 — gross profit of $108.93M on revenue of $526.52M.
What is Core Laboratories Inc.'s market cap?
Core Laboratories Inc. (CLB) has a market capitalization of about $617.00M, based on the latest data in our nightly-refreshed cache.
When does Core Laboratories Inc.'s fiscal year end?
CLB's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CLB stock?
At today's market cap of $617.00M, Core Laboratories Inc. is priced for free-cash-flow growth of about 10.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $25.82M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Core Laboratories Inc.'s official SEC filings (10-K and 10-Q), covering 5 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.